chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a physician and described the occurrence of injection site reaction in a 52-year-old female subject who was vaccinated with influenza virus vaccine (anti flu vaccine, manufacturer unspecified) for prophylaxis.  Concurrent medications included montelukast sodium (Singulair), conjugated estrogens (Premarin), mometasone furoate (Nasonex) and unknown "Zalaten".  On 25 October 2007 the subject received unspecified dose of anti flu vaccine (unknown, right arm).  On 25 October 2007, at an unknown time after the vaccination with anti flu vaccine, the subject experienced injection site reaction, injection site redness and swelling injection site.  The reporting physician stated "the person administering the vaccine may have hit the bursa" (bursa injury).  Medical attention was required at the physician's office.  At the time of reporting the events were worse.  The physician considered the events were possibly related to vaccination with anti flu vaccine.
Within one month of shot, swelling of Lymph Node in right armpit. Swelling did not go away by got very large. By October, Dr. ordered a  biopsy. Results: I was diagnosed will SLL.
Blurred vision. Near vision suddenly and drastically became blurred and remains so. The degradation of my vision was so bad that I went from wearing readers that were only a magnification of only a 1.25 to suddenly, readers that are a 2.5 magnification just to be able to read standard font.
Hives over entire body within 3 hrs of vaccine. Also stated, frequent throat clearing.
Pain from  shoulder joint to mid bicep,  heat but no redness, swollen knot about 3 inches in circumference. Unable to move arm from the shoulder. Lasted 3 days (Friday-Sun). Mild pain on Monday but able to move shoulder. Low grade fever (99.8) starting on Sun (injection was Friday) Nausea for about 2 days (Sun/Mon) Mild headache for about 2 days (Sat/Sun)
Swelling of feet, legs, hands, arms and face; Swelling of feet, legs, hands, arms and face; itching in face and neck; This is a spontaneous report from a contactable consumer (Patient). A 53-year-old female patient received bnt162b2, dose 2 via an unspecified route of administration, administered in Arm Left on 06Apr2021 17:30 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation at the age of 53-year-old.  Medical history included severe back issues and "I have had 6 back surgeries", allergy to all Nsaids. The patient previously received bnt162b2, dose 1 administered in Arm Left on 16Mar2021 08:30 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation at the age of 53-year-old. Concomitant medications included hydrocodone, cefixime (FLEXERIL [CEFIXIME]), buprenorphine hydrochloride (BELBUCA), atorvastatin, clarithromycin, omeprazole, tinidazole (OTC-HP) taken for an unspecified indication, start and stop date were not reported. The patient was not diagnosed with COVID-19 prior to vaccination and hasn't been tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced swelling of feet, legs, hands, arms and face, itching in face and neck on 07Apr2021 02:00 with outcome of recovered in 2021. Therapeutic measures taken to all events included Benadryl and prescribed EpiPen. The events were assessed as medically significant. The events resulted in Emergency room/department or urgent care visit.  It was reported as: Swelling of feet, legs, hands, arms and face as well as itching in face and neck after about 8 hours of receiving 2nd dose. 1st dose was unremarkable.   The lot/batch number has been requested.
BREASTFEEDING; This spontaneous report received from a parent concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, transmammary, batch number: Unknown) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced breastfeeding. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of breastfeeding was not reported. This report was non-serious.
Fully vaccinated with Pfizer vaccine. COVID sysmptoms began on 08/08/2021 diagnosed with COVID on 08/12/2021.
passed out; Violent pains in stomach; lost all use in limbs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): MOD-2023-729228 (Moderna).  An elderly female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 4 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: LOSS OF CONSCIOUSNESS (hospitalization, medically significant), 2 weeks after the suspect product(s) administration, outcome "unknown", described as "passed out"; ABDOMINAL PAIN UPPER (hospitalization), 2 weeks after the suspect product(s) administration, outcome "unknown", described as "Violent pains in stomach"; MUSCULOSKELETAL DISORDER (hospitalization), 2 weeks after the suspect product(s) administration, outcome "unknown", described as "lost all use in limbs". The patient underwent the following laboratory tests and procedures: tests: unknown result. Clinical course: Reporter was looking for advice on safety of the latest covid spring vaccine, as he was unable to get any information from the local doctors. At present time, they were both unsure whether or not to have the vaccine. He and his wife were in mid to late seventies, When she had the fifth (Pfizer vaccine), 2 weeks later she had violent pains in stomach, lost all use in her limbs and passed out, then finished up in Hospital for a day having tests. When she had the sixth (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5), 2 weeks later, she got Oedema in her ankles and feet, together with her immune system attacking her hands arms and shoulders, which was put down to Rheumatoid Arthritis. The above situations seems too co-insidential. Reporter at that time put the information on the "yellow card system" His wife was also in part remission after having chemotherapy for T cell lymphoma and also took methatrexate for the arthritis.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Same day, low grade fever. Next few days he had fever, myalgia, fatigue, headache. Those symptoms mostly resolved after 3 days, then he had mild shortness of breath with exertion.
Vaccine was administered. Within approximately 1 to 2 minutes after administration patient got very clammy, lost color in her face and passed out while sitting in the chair. Patient regained consciousness within a matter of seconds. Patient remained seated and was observed for another 30 minutes before she was allowed to leave facility. Patient did state that she has a history of fainting with vaccinations.
Day #1&2: severe pain & swelling, unable to use affected arm. Day #3&4: continued severe pain, swelling, tenderness PLUS hives & redness of entire upper arm.
A little bit of an adverse reaction but it's nothing; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (A little bit of an adverse reaction but it's nothing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (A little bit of an adverse reaction but it's nothing). At the time of the report, VACCINATION COMPLICATION (A little bit of an adverse reaction but it's nothing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.   Reporter did not allow further contact
Nosebleed that did not stop after several hours of direct pressure. Required visit to Emergency Room and ENT consult.  Bleeding identified as anterior nasal and the mucosa appeared friable.  Resolved with placement of hydrostatic gel.
Runny nose - four - five days; sore throat for two days. Treatment - increased water intake and rest. Went to doctor on June 1st
aches; chills; Fever 101.3 F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), CHILLS (chills) and PYREXIA (Fever 101.3 F) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (aches), CHILLS (chills) and PYREXIA (Fever 101.3 F). At the time of the report, PAIN (aches), CHILLS (chills) and PYREXIA (Fever 101.3 F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: TCR. Follow up is NNI.
i will say i didnt know about this site until today so i had side effects with the first vaccine as well. those were arm soreness,  runny nose, sore throat , headache , body aches, malaise, these lasted 5 days.  My second dose effects were pain in injection arm not just site, a welt, nausea , headache , fever of 100.3 for 8 hours ( my normal temp is 96 as i have hashimotos ) sleepiness, no appetite . my heart rate also went up to 102 for about 4 hours the second day after injection. i must note i am a athlete and my normal heart rate is 52-56 and only goes above 100 when i exercise . all my symptoms were gone by hour 48
1/20/21 Arm  L site  red  with 3 penny size areas.  No swelling but a little itchy.   1/21  Left  arm site is red, swollen, firm with discomfort and itchy. Applied Cortisone cream (over counter).  1/22 Arm site still red ,itchy, raised, size about 3 inches around. Applied Cortissone . 1/23 Site  much better with a small amount of redness, small amount of discomfort.  Next  day site normal.
Bruising, pain, and hard lump approximately the size of a large marble at site of injection. Still present on 7/7/23 - nearly 2 weeks post injection. Lump size has not decreased, nor has pain or bruising decreased.
Pt felt dizzy like she might faint had chest pain and funny taste in mouth. Pt rested in waiting area checked BP -140/80. Pt felt a little better after 15 min. Checked back with pt at 7:30 she was feeling better.
Pt received the vaccination  on Tuesday 9/21/10 and on 9/22/10 noticed a rash surrounding the injection site that is warm to the touch. Pt was referred to her physician for follow up.
Severe pain right foot at base of big toe - same as possible gout attack for past two years. Could not walk on foot and very sensitive to touch. Took Mitigare and was nauseous all day. Next morning pain subsided but nausea stayed with me  by Saturday morning everything was back to normal
Varivax exposed to a temperature excursion was administered; This spontaneous report was received from a physician concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.     On 21-DEC-2021 the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U020238 with expiration date: 28-JUN-2023, (dose, route of administration not reported) as prophylaxis, that had experienced a temperature excursion at 8.2 Fahrenheit degrees for 1 hour and 30 minutes. There were no previous temperature excursions.
Patient experienced shortness of breath, seen in ED, seen in cardiology clinic for possible pericarditis
1 hour after the 2nd dose, my arm started getting a red raised rash on my whole arm down to back of hand. I had golf ball size lump at injection site and lymph node in armpit was apple size swollen. That started happening 1 hour after vaccine and then maybe 6 hours later I started running a fever up to 104 so I kept taking Tylenol every 4 hours and I remained at 103.8. Other than that, the rash and swelling stayed for 5 days and I just had fever and the symptoms of fever like chills, sweats, and exhaustion. I called my Doctor multiple times and she kept saying it was normal and I spoke with the RN in the same office recently and she said that it wasn't normal. I did call doctor again and she assured me everything was fine so I did not go to urgent care. Covid symptoms started 01/06/2022. I had symptoms starting on the 5th and positive test on the 6th. I had extreme sore throat and exhaustion like I've never felt before and by the 7th I was just maintaining the symptoms but the brain fog started to set in and I had to really think about simple tasks. I maintained sore throat, exhaustion, and brain fog for 4 days, then on the 5th day my airway swelled up and so I went to urgent care because I couldn't breathe or swallow and urgent care prescribed me steroid and that helped. I didn't feel well until a week ago. Fever was minimal at 99.
NO ADVERSE REACTIONS. POLIO WAS NOT NEEDED FOR PATIENT. EXTRA DOSE WAS GIVEN.
This case was reported by a consumer via call center representative and described the occurrence of influenza in a 54-year-old female patient who received Flu Seasonal QIV Dresden for prophylaxis. Co-suspect products included BREO ELLIPTA inhalation powder (batch number 8ZP2569, expiry date 31st May 2020) for chronic obstructive pulmonary disease and VENTOLIN HFA inhaler (batch number 8ZP2225, expiry date 31st December 2019) for chronic obstructive pulmonary disease. On 7th December 2018, the patient received Influenza vaccine Quadrivalent 2018-2019 season. On an unknown date, the patient started BREO ELLIPTA (inhaled) at an unknown dose and frequency and VENTOLIN HFA (inhaled) 2 puff(s) 4 times daily (8 puff(s) daily). In December 2018, several days after receiving Influenza vaccine Quadrivalent 2018-2019 season and less than a month after starting BREO ELLIPTA and VENTOLIN HFA, the patient experienced influenza, nasal congestion, appetite lost, lightheadedness, weakness and product use in unapproved indication. On an unknown date, the outcome of the influenza, nasal congestion, appetite lost, lightheadedness, weakness and product use in unapproved indication were unknown. It was unknown if the reporter considered the influenza, nasal congestion, appetite lost, lightheadedness and weakness to be related to Influenza vaccine Quadrivalent 2018-2019 season, BREO ELLIPTA and VENTOLIN HFA. Additional details were provided as follows: Approximately 2 weeks before the date of reporting, the patient received an unknown manufacturer's flu shot. The vaccination date of Flu vaccine was reported as 7th November 2018, however, as per the description it was changed to 7th December 2018. A few days after the Flu shot, she came down with the flu. At the time of the flu, the patient was taking BREO 200/25 once daily for COPD and also taking VENTOLIN HFA, as needed, but as of developing flu symptoms, she had increased her dosing, which led to product used for unapproved indication. The patient experienced lightheadedness, losss of appetite, and head congestion. The patient was also weak. The reporter did not consent for follow-up.
FATIGUE, HEADACHE, MUSCLE PAIN, JOINT PAIN, CHILLS, NAUSEA, AND FEVER RESOLVED IN 4 DAYS Narrative:
On November 1st, I lost my voice. I am not talking like my regular self. My doctor says that she think it's due to the RSV vaccine. She said when you get the RSV vaccine, it's a live virus they put in you. I dont think I will ever get it again.
Moderna COVID vaccine given for 2nd dose, 1st dose was Pfizer COVID vaccine.  No signs or symptoms of adverse effects noted within 15 minutes of administering the vaccine.
Passed out, unconscious ~27 hours after vaccine. EMS transport and lost consciousness another two times.
got sick for over a week; Initial information was received on 08-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case is linked to case 2020SA314526 (same reporter).  This case involves a female patient (unknown age) who got sick for over a week (illness), after receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious got sick for over a week (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021 at 2:23 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Jan-2021 at 2:23 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.    On 12-Jan-2021, Excursion time was 08 AM, temperature was 34 and 9 AM, temperature was 34, total doses given for the day was 30, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 08-Jan-2021, vial was moved to clinic on 12-Jan-2021. 03 vials were sent to clinic. Vaccine BUD date was 07-Feb-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.    Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 65-year-old female patient who received SHINGRIX. Previously administered products included ZOSTAVAX (received in 2016). In April 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In April 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. The reporter considered the injection site pain to be possibly related to SHINGRIX. Additional details were reported as follows: The reporter's wife received SHINGRIX vaccine about a week before him and had soreness at site of injection on the day of the injection.
Rash developed the day of administration. Per pt getting progressively worse. Itching, redness and rash. Pt was advised to apply some BENADRYL cream for now. Contact MD.
Soreness of injection site about 10 hours after injection time lasting about 2 days.  5 days after, severe pain in the underarm area 6 days after, severe pain in the underarm area in addition to pins and needles running from armpit to finger tips, sore neck and a runny nose began.
The next morning I woke up and thought my mouth hurt then the more I thought about it I realized it didn't hurt but it was numb on the left side, like I had Novocain wearing off.   It is getting a little better but is still numb a week later.
This spontaneous report was received from a registered nurse and refers to multiple unknown patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On multiple unknown dates, the patients were vaccinated with improperly stored dose of PEDVAXHIB lot # L006545 with expiration date 16-NOV-2017 and lot # L014428 with expiration date 12-MAR-2018 (dose and route of administration were not reported). The vaccine underwent a temperature excursions below 36 degrees Fahrenheit for unknown time (reported as "more than 25 times"). It was reported that Data logger was used. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
DAD CALLED OFFICE ON 10/30/09 AM AND STATED THAT PATIENT WOKE UP WITH A RASH (HIVES) ALL OVER AND ITCHING.  SHE RECEIVED THE LIVE INTRANASAL H1N1 VACCINE THE PREVIOUS AFTERNOON.  NO OTHE SYMPTOMS ACCORDING TO DAD.
Initial misuse report received from a healthcare professional on 12 July 2013. An 11-year-old patient's record was not checked and the patient was administered another dose of MENACTRA vaccine 1 year after the primary dose. No information was provided regarding the patient. No adverse event was reported. Documents held by sender: None.
Bilateral lower extremity swelling with the distal leg redness as well as hand swelling as well as change in mental status. Tested positive for COVID19 prior to admission. MD stated the patient was completely asymptomatic and most likely the test was false positive.